Emergent BioSolutions (EBS) Misses Q1 EPS by 25c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.55 +2.25%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
BBGI, COHR, LVWD, More
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
BBGI, COHR, LVWD, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($0.03), $0.25 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $117.8 million versus the consensus estimate of $140.42 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
- Beasley Broadcasting Group (BBGI) Tops Q2 EPS by 4595c
- ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
